November 2024
The global blockchain in healthcare market size reached USD 0.76 billion in 2022 and is projected to hit around USD 14.25 billion in 2032, expanding at a healthy CAGR of 34.02% from 2023 to 2032.
Unlock Infinite Advantages: Subscribe to Annual Membership
Blockchain Technology has the potential to develop an efficient, transparent, safe, and effective method of communicating data all over healthcare.
A blockchain is described as a growing set of cryptographically linked records known as blocks. Each block includes a cryptographic hash of the previous block, as well as a time and date, and transaction data. The timestamp ensures that the transaction data is actually at the time the block was published and so may be hashed. Since each block carries information about the one that came before it, they form a chain, with each new block reinforcing the ones that came before it. As a result, blockchains are resistant to data change since data in any one block cannot be modified retrospectively without affecting all subsequent blocks once it has been recorded.
Permission Blockchains and Permission-Less Blockchains are the two main types of blockchain in healthcare. Permissioned blockchains, also known as private blockchains, require authorization before use and can only be accessed by those who have been granted access. These provide high customizability, access controls, improved scalability, dependability, and more efficient performance.
On-premise and cloud-based deployments are utilized in supply chain management, clinical data interchange and interoperability, claims adjudication and billing management, and other applications. Healthcare providers, pharmaceutical companies, healthcare payers, and others are among the end-users of blockchain in healthcare.
The increased prevalence of information leaks and data breaches, as well as the growing need to tackle these issues, are driving market expansion. The implementation of the technology is being driven by strategic actions by key parties, high demand to prevent drug counterfeiting, and a need for effective health data management systems.
According to the OECD, a new blockchain application called Research Foundry has evolved to enable the management of rights and consent for the sharing and access of health data, software code, metadata, and other items related to healthcare R&D. Furthermore, increased investment in the development of effective healthcare record systems, wearable device cryptography, and medical examination systems is expected to give profitable prospects in the near future for this market.
In the field of healthcare, the urgency of development is increasing at tremendous speed. Today, there is a demand for high-quality healthcare facilities that are backed by innovative and cutting-edge technology. Blockchain would play a major role in revolutionizing the healthcare sector in this case. Furthermore, the healthcare environment is shifting toward a patient-centered strategy that emphasizes two key aspects: accessible services and appropriate healthcare resources. Blockchain improves the ability of healthcare organizations to deliver enough patient care and high-quality health facilities. Another time-consuming and repetitive activity that contributes to high healthcare expenses may be resolved easily with this technology. Citizens can participate in health research initiatives using Blockchain technology.
Consumers have embraced telehealth, moving from 11% using it in 2019 to 76% who are now interested in using telehealth moving forward. This shift is driven by the need to avoid exposure to COVID-19, with over 70% of in-person visits being cancelled. Consumers are also increasingly likely to use telehealth going forward, with 76% of survey respondents indicating they are highly or moderately likely to use telehealth, and 74% of users reporting high satisfaction.
Providers have also rapidly adopted telehealth. To meet the increased demand, health systems, independent practices, and behavioral health providers have scaled their telehealth offerings to fill the gap left by cancelled in-person appointments. This shift is reflected in the number of telehealth visits, which has increased 50-175 times since before COVID-19. Providers also view telehealth more favorably (57%) and are more comfortable using it (64%) than they did before COVID-19.
The COVID-19 pandemic boosted the global blockchain technology in the healthcare market, owing to the increased usage of cutting-edge technologies such as blockchain in the healthcare business.
As more and more people throughout the world became infected with the fatal virus, the demand for healthcare increased tremendously, and several healthcare facilities in several countries made excellent use of blockchain technology. This was done to considerably improve resource and operation planning effectiveness.
Furthermore, a large number of clinics and hospitals throughout the world were redesigned to expand hospital capacity for COVID-19 patients, which increased the demand for blockchain technology in healthcare. As a result, COVID-19 has had a beneficial market impact.
The increasing implementation of blockchain as a service (BaaS) is likely to propel the blockchain in the healthcare market ahead. Blockchain technology has the potential to provide innovative solutions to the healthcare industry's challenges, such as supply chain management, smart contracts, the confidentiality of personal health information, technical issues in data management, the enablement of alternative payment models, and virus outbreak tracking.
Furthermore, the cost-effectiveness of Blockchain technology in healthcare is driving market expansion. Many firms have begun to leverage blockchain technology to address critical concerns in the healthcare industry, increasing the bar for security standards. The digital ledger system is incredibly secure, does not require a third-party administrator, and has a high level of transparency. Public blockchain technology has been built to work with the greatest medical data security standards, boosting the business's value. Furthermore, the low cost of using public blockchain technology in healthcare is a key driver driving business expansion. The high grade of security procedures, dependable portal services, and anonymous nature are predicted to favorably affect market demand.
Reluctance to Share Information, a lack of a centralized authority and a set of common standards, a lack of technological infrastructure, and a shortage of trained experts will be the primary barriers to the growth of the Global Blockchain In the Healthcare Market. The main issue with using this modern technology in medical institutions is a lack of expertise. Blockchain applications are still in their infancy stages and require further work for technological investigation and study. It does, however, apply to the responsibilities of health organizations and regulators.
Technological innovations are considerably altering the Blockchain in the Healthcare Market. As the need for blockchain technology grows, the leading players in the healthcare blockchain market are focused on providing sophisticated technological solutions for the healthcare industry in order to increase their market position.
In 2022, the public network segment dominated the global market by network type. The rising use of public networks for data management is the primary driver of the large share of the public segment. Ethereum, a public network, is currently one of the most widely used technologies in healthcare. It is also referred to as a "permissionless" blockchain technology. The main factors driving the growth of these public networks are low cost and access to a larger database.
In 2022, the supply chain management application category represented more than 23% of the blockchain technology market share in the healthcare market. Blockchain applications aid in the preservation of data integrity. Additionally, the technology assists pharmaceutical businesses in facilitating interoperability with the Internet of Things (IoT) devices. It also aids in the recruitment of clinical trial candidates and the regulation of the drug supply chain. Blockchain has the potential to revolutionize the healthcare industry by cutting operational costs, reducing data corruption, and optimizing healthcare processes. During the projection period, the clinical trials & eConsent segment are predicted to increase at a significant rate. Leveraging technology in clinical trials allows for more effective data management and security. The incorporation of blockchain technology enables clinicians to safely connect internally.
In 2022, by end-user, the biopharmaceutical & medical device companies’ segment had a market share of more than 47%. This is due to enormous R&D investments, the requirement to secure data interchange and interoperability, and the extensive data management performed by these organizations in pharmaceutical research and development areas. The growing use of technology for critical functions such as verifying the authenticity of returned drugs, counterfeit prevention, compliance with the pharmaceutical supply chain, transparency and traceability in clinical trials, and improving the reliability and quality of clinical trial data is expected to contribute to the segment's large share.
Due to different initiatives taken by regional governments to minimize data leaks, Europe held the largest market share in 2022. For instance, the EU government proposed the General Data Protection Regulation in 2018 (GDPR). The implementation of GDPR, together with the massive expansion of blockchain technology, is projected to give more chances for companies in the region. During the projected period, North America is expected to have the second-largest market share. The primary driver of regional growth is the rising demand for medical record security.
Transparency In The Supply Chain
E-Health Records Centered On The Patient
Insurance And Supply Chain Settlements Using Smart Contracts
IoT Security For Remote Monitoring
Remote Monitoring Of IoT Security
Blockchain technology can aid in the growth of the global healthcare business by saving money and encouraging further investment in critical resources. With so much at risk, it's difficult to believe that the current inefficient, highly bureaucratic, and failing healthcare business will continue. It is time for patients, practitioners, and executives to adopt the technological and system-based innovations at their disposal.
November 2024
November 2024
November 2024
November 2024
Deepa has certified the degree of Master’s in Pharmacy in the Pharmaceutical Quality Assurance department from Dr D.Y. Patil College of Pharmacy. Her research is focused on the healthcare industry. She is the author or co-author of four Review Articles, which include Solid dispersion a strategic method for poorly soluble drugs and solubility improvement techniques for poorly soluble drugs, Herbal Drugs Used In Treatment Of Cataracts, Nano sponges And Their Application in Cancer Prevention and Ayurvedic Remedies of Peptic ulcer. She has also published a Research Article on the Formulation and Evaluation of Mucoadhesive Tablets of Miconazole cocrystal which was published in GIS Science Journal Volume 9 Issue 8. Her passion for secondary research and desire to take on the challenge of solving unresolved issues is making her flourish is the in the research sector.